PRESAGE BIOSCIENCES
Presage has developed a means of assessing tumor response to drugs or RNA interference agents without the limitations inherent to systemic administration. The Presage clinical surrogate approach enables drug companies to halt development projects for compounds that show no efficacy in the native tumor microenvironment. In addition, the Presage approach can identify drug targets using RNA interference without concern regarding localization or distribution of systemically administered RNAi agents. Presage technology can also be used to identify effective drug combinations in ways that more directly measure the efficacy of such combinations than otherwise possible.
PRESAGE BIOSCIENCES
Industry:
Biotechnology Health Care Medical
Founded:
2008-11-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.presagebio.com
Total Employee:
11+
Status:
Active
Contact:
4087333323
Total Funding:
32.57 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Google Maps Font Awesome
Similar Organizations
CH Biomedical
CH Biomedical develops VAD technology utilizing an innovative MagLev pump design.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Current Employees Featured
Richard Klinghoffer CEO @ Presage Biosciences
CEO
2018-06-01
James Olson Founder @ Presage Biosciences
Founder
2008-01-01
Richard Klinghoffer Chief Scientific Officer @ Presage Biosciences
Chief Scientific Officer
Founder
Investors List
LabCorp Venture Fund
LabCorp Venture Fund investment in Venture Round - Presage Biosciences
Bristol-Myers Squibb
Bristol-Myers Squibb investment in Venture Round - Presage Biosciences
InHarv Partners
InHarv Partners investment in Venture Round - Presage Biosciences
Takeda Ventures
Takeda Ventures investment in Convertible Note - Presage Biosciences
Celgene
Celgene investment in Series D - Presage Biosciences
Takeda Ventures
Takeda Ventures investment in Series D - Presage Biosciences
Takeda Ventures
Takeda Ventures investment in Venture Round - Presage Biosciences
David Wu
David Wu investment in Seed Round - Presage Biosciences
Official Site Inspections
http://www.presagebio.com Semrush global rank: 11.36 M Semrush visits lastest month: 162
Unable to get host informations!!!
More informations about "Presage Biosciences"
Team and Board – Presage Biosciences
Presage Biosciences 530 Fairview Avenue North Suite 1000 Seattle, WA 98109 info@presagebio.comSee details»
Presage Biosciences - Crunchbase Company Profile
Organization. Presage Biosciences . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. …See details»
Presage Biosciences, Inc. | LinkedIn
#PresageBio is looking forward to #ASCO2024 this week, hope to see you there! 2 Like Comment Share Presage Biosciences, Inc. 2,022 followers 9mo Report this post ...See details»
Presage Biosciences 2025 Company Profile: Valuation, …
Presage Biosciences General Information Description. Developer of an oncology technology designed to improve the way drugs are developed and targeted. …See details»
Presage Company Profile - Office Locations, Competitors ... - Craft
Presage has 5 employees at their 1 location and $32.6 m in total funding,. See insights on Presage including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Presage Biosciences - Overview, News & Similar companies
Feb 16, 2021 www.presagebio.com. Revenue <$5 Million. Industry Business Services General Business Services . Most Recent Scoops. Aug 4 2022. Left Company. Feb 17 2021. Funding. …See details»
Presage Biosciences, Inc. - Phone, Email, Employees, CEO, VP, 2022
Presage Biosciences, Inc. (https://www.presagebio.com) location in Washington, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Presage sets the stage for commercial expansion with $13M
Mar 2, 2021 Presage also partners with oncology-focused pharmaceutical companies through strategic alliances to provide preclinical data to discover effective drug combinations. Presage …See details»
About – Presage Biosciences
Nine issued US patents “A method of evaluating one or more candidate agents, wherein at least one of the one or more candidate agents is a drug, comprising: introducing the one or more candidate agents to one or more positions in a …See details»
Presage Biosciences, Inc. Staff Directory & Email Format
Explore Presage Biosciences, Inc. staff directory for direct access to contact details on 19 employees including email format, email address and phone numbers.See details»
Presage Biosciences, Inc. on LinkedIn: Team and Board
For World Cancer Day this year, I recruited a team of 30 people to participate in Cycle for Survival (CFS). CFS is a 4 hour relay-style bike ride dedicated to fundraising for rare cancer research ...See details»
Home - Presage
The funds that your organization invests in a Presage solution shall be returned to you via improvements in efficiency and compliance with organizational policies and procedures. This …See details»
Presage Biosciences and Millennium Enter Into Cancer Research …
Nov 12, 2014 For more information, visit www.presagebio.com. Contacts. Presage Contact: Rathbun Communications Julie Rathbun, 206-769-9219 [email protected] or Millennium …See details»
Publications – Presage Biosciences
Presage Biosciences 530 Fairview Avenue North Suite 1000 Seattle, WA 98109 info@presagebio.comSee details»
Presage Announces Collaboration with Pure Biologics to …
SEATTLE, Feb. 6, 2023 /PRNewswire/ -- Presage Biosciences, a biotechnology company whose mission is understanding the complexity of drug response in the tumor microenvironment, …See details»
Wendy Jenkins E-Mail & Telefonnummer | Presage ... - RocketReach
Wendy Jenkins, ansässig in Seattle, WA, USA, ist derzeit Senior Director für klinische Operationen bei Presage Biosciences, Inc.. Wendy Jenkins bringt Erfahrung aus vorherigen …See details»
News – Presage Biosciences
Presage Biosciences, a biotechnology company whose mission is understanding the complexity of drug response in the tumor microenvironment, today announced it has entered into a new …See details»
Federal government announces support for cutting-edge, AI- and …
17 hours ago OmniaBio Inc. is a technology-focused, global cell and gene therapy contract development and manufacturing organization. A subsidiary of the Centre for …See details»
Home - Sage Bio, Inc.
We are transforming the way you manage your own health. Our mission is to address common medical challenges, such as ordering your own labs, understanding your complex lab reports, …See details»
Clinical Collaboration – Presage Biosciences
Clinical development of novel oncology agents takes years, costs millions of dollars, and the likelihood of FDA approval is less than 10%.Phase I trials provide preliminary safety and …See details»